New diabetes clinical trial: A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)

Published on: 2026-07-15T04:00:00Z
Conditions: Diabetic Retinopathy; Macular Edema
Interventions: Drug: MK-8748; Drug: Aflibercept
Sponsors: Merck Sharp & Dohme LLC
Not yet recruiting
https://ift.tt/DPEbiCI